Citations |
Int J Infect Dis. 2021 Apr 14;S1201-9712(21)00346-5.<br>J Clin Microbiol. 2020 Aug 24;58(9):e00932-20.<br>ACS Infect Dis. 2021 Jun 30.<br>Acta Microbiol Immunol Hung. 2021 Jul 29.<br>Adv Ther (Weinh). 2024 Jan 12.<br>Antibiotics (Basel). 2021 Sep 14;10(9):1110.<br>Antibiotics (Basel). 2021, 10(11), 1341.<br>Antibiotics (Basel). 2022, 11(10), 1280.<br>Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00414-18. <br>Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00433-18.<br>Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00282-18. <br>Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00873-18.<br>Antimicrob Agents Chemother. 2022 Jun 1;e0240221.<br>Antimicrob Agents Chemother. 2023 Jan 23;e0145922.<br>bioRxiv. 2021 Mar 13.<br>Biosens Bioelectron. 2021 Jul 21;193:113526.<br>Infect Drug Resist. 2020 Aug 18;13:2883-2890.<br>Infect Drug Resist. 2021 Jun 30;14:2499-2507.<br>Int J Antimicrob Agents. 2018 Aug;52(2):269-271.<br>Int J Antimicrob Agents. 2024 May 14:107206.<br>Int J Infect Dis. 2020 Apr;93:252-257. <br>Int J Med Microbiol. 2021 Oct;70(10).<br>Int J Mol Sci. 2021, 22(6), 3051.<br>J Antimicrob Chemother. 2021 Feb 11;76(3):653-658.<br>J Antimicrob Chemother. 2021 May 6;dkab141.<br>J Antimicrob Chemother. 2022 Jul 15;dkac232.<br>J Antimicrob Chemother. 2023 Feb 13;dkad032.<br>J Infect Dev Ctries. 2021 Mar 31;15(3):404-414.<br>J Infect Dis. 2019 Jul 2;220(3):484-493. <br>Microbiol Spectr. 2022 Aug 16;e0139022.<br>Microbiol Spectr. 2022 Aug 24;e0203522.<br>Microbiol Spectr. 2022 Dec 8;e0303822.<br>Microbiol Spectr. 2023 Nov 20:e0304723.<br>RSC Adv. 2023 Nov 30;13(49):34884-34890.<br>Sci Rep. 2022 Oct 7;12(1):16814.<br>Antibiotics (Basel). 2023 Jul 20, 12(7), 1212.<br>Antibiotics (Basel). 2024 May 1, 13(5), 416.<br>Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02260-16.<br>Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01809-18.<br>Antimicrob Agents Chemother. 2019 Aug 23;63(9):e01374-19.<br>Antimicrob Agents Chemother. 2019 Sep 16;63(12):e01515-19.<br>Antimicrob Agents Chemother. 2020 Feb 21;64(3):e02025-19.<br>Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00409-20.<br>Antimicrob Agents Chemother. 2023 May 18;e0160322.<br>Antimicrob Agents Chemother. 2023 May 31;e0033923.<br>Antimicrob Agents Chemother. 2023 Sep 6;e0052823.<br>Antimicrob Agents Chemother. 2023 Sep 8;e0030123.<br>Biomed Res Int. 2018 Jul 2;2018:3579832. <br>BMC Microbiol. 2020 Jun 29;20(1):187.<br>BMC Microbiol. 2019 Nov 1;19(1):240.<br>Int J Med Microbiol. 2020 Jul;69(7):928-931.<br>J Antimicrob Chemother. 2017 Jul 1;72(7):1930-1936.<br>J Antimicrob Chemother. 2017 Sep 1;72(9):2483-2488.<br>J Antimicrob Chemother. 2020 Sep 1;75(9):2609-2615.<br>J Antimicrob Chemother. 2024 Apr 2:dkae097.<br>J Clin Microbiol. 2023 Apr 18;e0164722.<br>Microb Drug Resist. 2020 Apr;26(4):334-340.<br>Microbiol Spectr. 2023 Apr 24;e0069223.<br>Preprints. 2023 Jun 21.<br>[1]Livermore DM, et al.
Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104).
J Antimicrob Chemother. 2012 Jun;67(6):1354-8.<br>[2]Berkhout J, et al. Pharmacokinetics and penetration of GR20263 and avibactam into epithelial lining fluid in thigh- and lung-infected mice. Antimicrob Agents Chemother. 2015 Apr;59(4):2299-304.<br>[3]Ehmann DE, et al.
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11663-8.<br>[4]Zhang W, et al. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae. Antimicrob Resist Infect Control. 2018 Nov 21;7:142. |